Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues

Ralph H. B. Benedict*, Maria Pia Amato, John DeLuca, Jeroen J. G. Geurts

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Multiple sclerosis is a chronic, demyelinating disease of the CNS. Cognitive impairment is a sometimes neglected, yet common, sign and symptom with a profound effect on instrumental activities of daily living. The prevalence of cognitive impairment in multiple sclerosis varies across the lifespan and might be difficult to distinguish from other causes in older age. MRI studies show that widespread changes to brain networks contribute to cognitive dysfunction, and grey matter atrophy is an early sign of potential future cognitive decline. Neuropsychological research suggests that cognitive processing speed and episodic memory are the most frequently affected cognitive domains. Narrowing evaluation to these core areas permits brief, routine assessment in the clinical setting. Owing to its brevity, reliability, and sensitivity, the Symbol Digit Modalities Test, or its computer-based analogues, can be used to monitor episodes of acute disease activity. The Symbol Digit Modalities Test can also be used in clinical trials, and data increasingly show that cognitive processing speed and memory are amenable to cognitive training interventions.
Original languageEnglish
Pages (from-to)860-871
Number of pages12
JournalThe Lancet Neurology
Volume19
Issue number10
DOIs
Publication statusPublished - 1 Oct 2020

Cite this